J M Sánchez-Tapias

Author PubWeight™ 36.88‹?›

Top papers

Rank Title Journal Year PubWeight™‹?›
1 Hepatitis C virus infection mimicking primary Sjögren syndrome. A clinical and immunologic description of 35 cases. Medicine (Baltimore) 2001 1.97
2 Prevalence of hepatitis C virus infection in patients with antiphospholipid syndrome. J Hepatol 1999 1.44
3 Sensitivity to antiviral therapy may change after liver transplantation in patients with chronic hepatitis C virus infection. J Viral Hepat 2006 1.40
4 Comparative study of three methods for genotyping hepatitis C virus strains in samples from Spanish patients. J Clin Microbiol 1996 1.14
5 Relationship of the genomic complexity of hepatitis C virus with liver disease severity and response to interferon in patients with chronic HCV genotype 1b infection [correction of interferon]. Hepatology 1999 1.08
6 Donor and recipient IL28B polymorphisms in HCV-infected patients undergoing antiviral therapy before and after liver transplantation. Am J Transplant 2011 1.07
7 The prognostic relevance of the nonstructural 5A gene interferon sensitivity determining region is different in infections with genotype 1b and 3a isolates of hepatitis C virus. J Infect Dis 1998 1.03
8 Assessment of liver fibrosis before and after antiviral therapy by different serum marker panels in patients with chronic hepatitis C. Aliment Pharmacol Ther 2010 1.02
9 High amino acid variability within the NS5A of hepatitis C virus (HCV) is associated with hepatocellular carcinoma in patients with HCV-1b-related cirrhosis. Hepatology 2001 0.97
10 Hepatitis G virus infection in a haemodialysis unit: prevalence and clinical implications. Nephrol Dial Transplant 1997 0.96
11 Hepatitis B immunoglobulin discontinuation followed by hepatitis B virus vaccination: A new strategy in the prophylaxis of hepatitis B virus recurrence after liver transplantation. Hepatology 2000 0.94
12 Clinical trial: pharmacodynamics and pharmacokinetics of re-treatment with fixed-dose induction of peginterferon alpha-2a in hepatitis C virus genotype 1 true non-responder patients. Aliment Pharmacol Ther 2007 0.93
13 Hepatitis G virus infection in chronic liver disease. Gut 1998 0.90
14 Consensus conference on chronic viral hepatitis and HIV infection: updated Spanish recommendations. J Viral Hepat 2004 0.90
15 Incidence of non-A, non-B hepatitis after screening blood donors for antibodies to hepatitis C virus and surrogate markers. Ann Intern Med 1991 0.90
16 Prevalence and genotypes of GB virus C/hepatitis G virus (GBV-C/HGV) and hepatitis C virus among patients infected with human immunodeficiency virus: evidence of GBV-C/HGV sexual transmission. J Med Virol 1998 0.89
17 Influence of the genetic heterogeneity of the ISDR and PePHD regions of hepatitis C virus on the response to interferon therapy in chronic hepatitis C. J Med Virol 2001 0.89
18 Hepatitis G virus infection in chronic hepatitis C: frequency, features and response to interferon therapy. J Hepatol 1997 0.88
19 Internal initiation of translation efficiency in different hepatitis C genotypes isolated from interferon treated patients. Arch Virol 1999 0.88
20 Pre-treatment with prednisolone does not improve the efficacy of subsequent alpha interferon therapy in chronic hepatitis C. J Hepatol 2000 0.88
21 Microwave treatment of serum facilitates detection of hepatitis B virus DNA by the polymerase chain reaction. Results of a study in anti-HBe positive chronic hepatitis B. J Hepatol 1995 0.87
22 Infection with a novel human DNA virus (TTV) has no pathogenic significance in patients with liver diseases. J Hepatol 1999 0.86
23 Assessment of genotype and molecular evolution of hepatitis C virus in formalin-fixed paraffin-embedded liver tissue from patients with chronic hepatitis C virus infection. Lab Invest 2000 0.86
24 Incidence and risk factors of hepatitis C virus infection in a haemodialysis unit. Nephrol Dial Transplant 1997 0.85
25 Hepatitis C virus infection mimicking systemic lupus erythematosus: study of hepatitis C virus infection in a series of 134 Spanish patients with systemic lupus erythematosus. Arthritis Rheum 2000 0.83
26 Natural history of chronic persistent hepatitis B. Relationship between hepatitis B virus replication and the course of the disease. J Hepatol 1985 0.83
27 Permanent response to alpha-interferon therapy in chronic hepatitis C is preceded by rapid clearance of HCV-RNA from serum. J Hepatol 1996 0.83
28 Molecular evidence of mother-to-infant transmission of hepatitis G virus among women without known risk factors for parenteral infections. J Clin Microbiol 1999 0.82
29 Influence of the dynamics of the hypervariable region 1 of hepatitis C virus (HCV) on the histological severity of HCV recurrence after liver transplantation. J Med Virol 2001 0.82
30 Prevalence and route of transmission of infection with a novel DNA virus (TTV), hepatitis C virus, and hepatitis G virus in patients infected with HIV. J Acquir Immune Defic Syndr 2000 0.82
31 Hepatitis G virus infection in fulminant hepatic failure. Gut 1997 0.81
32 Comparative study of a modified competitive RT-PCR and Amplicor HCV monitor assays for quantitation of hepatitis C virus RNA in serum. J Med Virol 1999 0.81
33 Post-transfusional vs. sporadic non-A, non-B chronic hepatitis. A clinico-pathological and evolutive study. Liver 1988 0.80
34 Cryoglobulinaemia associated with hepatitis C virus: influence of HCV genotypes, HCV-RNA viraemia and HIV coinfection. J Viral Hepat 2007 0.80
35 Hepatitis B virus and hepatitis D virus replication in HBsAg-positive fulminant hepatitis. Hepatology 1990 0.79
36 Genetic evolution of hepatitis G virus in chronically infected individual patients. J Gen Virol 1998 0.78
37 [Post-transfusional hepatitis following cardiac surgery. Incidence, clinical aspects and prognosis]. Med Clin (Barc) 1987 0.77
38 Hepatitis G virus infection in primary Sjögren's syndrome: analysis in a series of 100 patients. Ann Rheum Dis 1998 0.77
39 Evolution of the NS3 and NS5B regions of the hepatitis C virus during disease recurrence after liver transplantation. Am J Transplant 2007 0.76
40 Hepatic disease in the Spanish toxic oil syndrome. A thirty months follow-up study. J Hepatol 1986 0.75
41 [Water-electrolyte disorders in hepatic cirrhosis with ascites]. Rev Clin Esp 1972 0.75
42 [Hepatitis B at an open institution for the mentally retarded. Immunogenic effect of a recombinant anti-hepatitis-B vaccine]. Enferm Infecc Microbiol Clin 1990 0.75
43 Genetic evolution of GB virus C/hepatitis G virus (GBV-C/HGV) under interferon pressure. Antiviral Res 2000 0.75
44 [The progression of hepatic fibrosis in chronic hepatitis C]. Gastroenterol Hepatol 2000 0.75
45 [Acute pseudotumoral alcoholic hepatitis]. Rev Clin Esp 1973 0.75
46 [Neutropenia caused by penicillin]. Med Clin (Barc) 1984 0.75
47 [Peritoneal infection in hepatic cirrhosis with ascitis]. Rev Clin Esp 1971 0.75
48 [Spontaneous retroperitoneal hematoma as a complication of acute cholestatic viral hepatitis]. Med Clin (Barc) 1987 0.75
49 [Laboratory diagnosis of hepatitis B]. Gastroenterol Hepatol 2001 0.75
50 Chronic hepatitis D in intravenous drug addicts and non-addicts. A comparative clinico-pathological study. J Hepatol 1988 0.75
51 [Epidemiology of hepatitis B in hospital personnel (author's transl)]. Med Clin (Barc) 1980 0.75